Do Lymph Nodes Enhance the Success of Immunotherapy?
University of California - San Francisco
New data show leaving lymph nodes intact until after immunotherapy could boost treatment efficacy
T-cells
Key Source of Loss of CAR T Cell Potency Identified
Dana-Farber Cancer Institute
Discovery may help design drugs that prevent T-cell therapies from losing their efficacy over time
New Insights into T Cell–Tumor Cells Interactions under Immunotherapy
UCLA Health
Study suggests immune responses could be strengthened even in patients showing no apparent clinical response
Can Clinical Flow Cytometry Gating Analysis Be Automated?
Zahraa Chorghay, PhD
Unsupervised and supervised algorithms can improve the efficiency and reproducibility of flow cytometric analysis
Novel CAR T-Cell Therapy to Combat Myositis
Friedrich-Alexander-Universität Erlangen-Nürnberg
CD19+ B cells-recognizing T cells may successfully treat autoimmune conditions like anti-synthetase syndrome
Controlling Conditions for CAR T Cells
Today's Clinical Lab
Download this application note for guidelines on ensuring a constant and stable environment for your CAR T cells
A Bull’s Eye Approach for Targeted Cancer Therapies
Mark M. Garner, PhD
Collaboration is at the heart of developing and deploying new targeted cancer solutions
Scientists Confirm Smallpox Vaccine Also Teaches T Cells to Fight Mpox
La Jolla Institute for Immunology
First study to provide evidence that the JYNNEOS vaccine induces a T cell response that recognizes mpox
5 Assays for Testing Adoptive Cell Therapy Quality
Daniel Millard, PhD
The benefits and limitations of five popular cell viability assays
Why Do Cancer Drugs Lead to Immune-Related Adverse Effects?
Zahraa Chorghay, PhD
Side effects of PI3Kδ immunotherapy could be mitigated by changing drug dosing